The Latin America, Middle East and Africa Electrophysiology Market would witness market growth of 11.8% CAGR during the forecast period (2022-2028).
Over the last few years, advancements in the electrophysiology (EP) devices field have accelerated, pushing the boundaries of product innovation paradigms. The emergence of leadless pacemakers was one such overarching trend in the electrophysiology devices market. Leadless pacemakers are a good alternative to traditional pacemakers, especially for individuals who have had device infections in the past. Traditional pacemakers are becoming a major source of worry since they are linked to a significant risk of morbidity. As a result, a strong foundation is being laid for a "never seen before" acceptance of leadless pacemakers.
Another underlying trend in the electrophysiology devices market is well-known healthcare centers offering unique electrophysiology programs that would address all treatment needs for heart rhythm abnormalities and related illnesses. UPMC Pinnacle, for example, is a premier healthcare center that provides a wide range of electrophysiological services. The most effective approach forward for companies to accelerate growth in the electrophysiological devices market remains to be effective remolding of product portfolios.
Due to the rapidly rising incidence of cardiovascular illnesses, LAMEA is expected to witness an increase in demand for electrophysiology market in the near future. Key market players in the region are likely to increase their investment due to the region's fast increasing healthcare infrastructure & rising healthcare expenditure levels. This is also likely to result in the launch of novel electrophysiological devices in this area. The emergence of indigenous players would result in fierce price competition, driving demand for low-cost gadgets in the region.
The expanding ageing population, technological advancements, and higher healthcare & advanced functionality funding are all driving the MEA electrophysiology market. Furthermore, the population is quickly ageing, increasing the risk of target diseases, cardiovascular diseases are on the rise in the region, and growing economies are driving market expansion. Technological improvements in electrophysiology will have a significant impact on the electrophysiology industry's growth.
The Brazil market dominated the LAMEA Electrophysiology Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $210.9 million by 2028. The Argentina market is poised to grow at a CAGR of 12.4% during (2022 - 2028). Additionally, The UAE market would witness a CAGR of 11.5% during (2022 - 2028).
Based on Type, the market is segmented into Electrophysiology Laboratory Devices, Electrophysiology Diagnostic Catheters, Electrophysiology Ablation Catheters, Electrophysiology Access Devices, and Others. Based on Electrophysiology Laboratory Devices Type, the market is segmented into ICE Ultrasound Imaging Systems, Electrophysiology X-Ray Systems, Radiofrequency (RF) Ablation Systems, 3D Mapping Systems & Electrophysiology Recording Systems, and Electrophysiology Remote Magnetic & Robotic Navigation Systems. Based on Electrophysiology Diagnostic Catheters Type, the market is segmented into Conventional, Ultrasound, and Advanced. Based on Electrophysiology Ablation Catheters Type, the market is segmented into Laser, Cryoablation, and Radiofrequency (RF) & Microwave. Based on End User, the market is segmented into Hospitals & Cardiac centres, and Ambulatory Surgery Centers. Based on Indication type, the market is segmented into Atrial Fibrillation, Atrial Flutter, AVNRT & WPW, and Others.Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Electrophysiology Market is Predict to reach $11.9 Billion by 2028, at a CAGR of 8.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, General Electric (GE) Co. (GE Healthcare), Medtronic PLC, Koninklijke Philips N.V., Siemens Healthineers AG, Johnson & Johnson, MicroPort Scientific Corporation, Stereotaxis Inc., and Acutus Medical, Inc.
By Type
By End User
By Indication type
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 